WHO Product ID
HCnda
Status
Prequalified
INN, dosage form and strength
Lamivudine/Nevirapine/Zidovudine Tablet 150mg/200mg/300mg
Basis of listing
Alternative Listing
Basis of alternative listing
Health Canada Access programme
Therapeutic area
HIV/AIDS
Type
Finished Pharmaceutical Product
Dosage form
Tablet
Applicant organization
Apotex Pharmachem Inc
PO Box 1976, Station Main
Brantford,
Ontario
N3T 5W5
Canada
FPP Manufacturing Site(s)
Apotex Pharmachem Inc
150 Signet Drive
Toronto,
Ontario
M9L 1T9
Canada